C oagulation tests and their association with postoperative blood loss after cardiac surgery with cardiopulmonary bypass

Correspondence to: Agnese Ozolina, Department of Anes­ thesiology and Cardiac Surgery of Pauls Stradins Clinical University Hospital, Kometas St. 14­7F, Riga, LV­1004, Latvia. E­mail: agnese_krauze@yahoo.com Background. Platelet count (PLT), activated partial thromboplastin time (APTT), prothrombin time (PT) and fibrinogen are standard coagulation tests used for patients undergoing cardiac surgery with cardiopulmonary bypass (CPB). Materials and methods. 83 adult cardiac surgery patients were en­ rolled into a prospective study. Blood samples for APTT, PT, PLT, fibrino­ gen were collected preoperatively (T0), on admission to the intensive care unit (T1), 6 and 24 hours postoperatively (T6, T24). 24­hour postopera­ tive blood loss (24h­PBL) was registered. Results. The highest APTT mean value was 47 ± 13 sec at T6, in­ creasing from the baseline by 37%. The lowest mean value of PLT was 140 ± 47 × 109/L at T24, decreasing from the baseline by 32.5%. PT and fibrinogen mean values at all time points were within the normal range. Correlation with 24h­PBL was shown by T0 and T6 fibrinogen (r = –0.5, r = –0.4, P < 0.0001) and T6 and T24 PLT count (r = –0.25; P = 0.02, r = –0.3; P = 0.01). Conclusions. Marked changes of coagulation tests from standard val­ ues after CPB were shown by APTT and PLT. PLT and fibrinogen may have the possible predictive value for greater 24h­PBL.

[1]  Wayne L Chandler,et al.  Activation of the Hemostatic System During Cardiopulmonary Bypass , 2011, Anesthesia and analgesia.

[2]  M. Rosenbloom Manual of Perioperative Care in Adult Cardiac Surgery , 2011 .

[3]  Eugene H Blackstone,et al.  Morbidity of bleeding after cardiac surgery: is it blood transfusion, reoperation for bleeding, or both? , 2011, The Annals of thoracic surgery.

[4]  D. Fries,et al.  Role of fibrinogen in trauma-induced coagulopathy. , 2010, British journal of anaesthesia.

[5]  S. Skrtic,et al.  Prophylactic fibrinogen infusion reduces bleeding after coronary artery bypass surgery , 2009, Thrombosis and Haemostasis.

[6]  C. Wade,et al.  The ratio of fibrinogen to red cells transfused affects survival in casualties receiving massive transfusions at an army combat support hospital. , 2008, The Journal of trauma.

[7]  W. Chandler Effects of hemodilution, blood loss, and consumption on hemostatic factor levels during cardiopulmonary bypass. , 2005, Journal of cardiothoracic and vascular anesthesia.

[8]  R. Whitlock,et al.  Bleeding in cardiac surgery: its prevention and treatment--an evidence-based review. , 2005, Critical care clinics.

[9]  B. Medalion,et al.  Preoperative use of enoxaparin is not a risk factor for postoperative bleeding after coronary artery bypass surgery. , 2003, The Journal of thoracic and cardiovascular surgery.

[10]  J. Chinn,et al.  Platelets and cardiopulmonary bypass , 1998, Perfusion.

[11]  P. Skillington,et al.  Heparin-rebound in the early postoperative phase following cardiopulmonary bypass. , 1995, The Australian and New Zealand journal of surgery.

[12]  R. Wilson,et al.  Changes in antithrombin, antiplasmin, and plasminogen during and after cardiopulmonary bypass. , 1985, The American surgeon.